The regulation of hepatic fatty acid oxidation is important from a medical standpoint several reasons. First, the rate of hepatic fatty acid oxidation is known to be extremely important for determining what fraction of the fatty acid received by the liver is packaged into very low density lipoprotein (VLDL) particles, and thus regulation of fatty acid oxidation is important for understanding mechanism regulating the hepatic production of lipoproteins and also their involvement in the process of atherosclersis. Second, when hepatic fatty acid oxidation is uncontrolled, as in diabetes mellitus Type I, ketoacidosis develops. In addition, it is known that various disorders of lipid metabolism result from altered thyroid status including alterations in hepatic fatty acid oxidation. The primary site for physiological inhibitor, malonyl-CoA. Previous work in this laboratory has shown that the activity of carnitive palmitoyltransfearse and its sensitivity to inhibition by malonyl- CoA change during fasting, diabetes, and in both hyperthyroid and hypothyroid states. Insulin and thyroid hormone are clearly involved in the regulatory mechanism for hepatic fatty acid oxidation. The long-term objective of this project is to understand the mechanisms by which hormones exert their control over camitine palmitoyltransferase.
The specific aims are: (a) to establish whether the recently discovered carnitive palmitoyltransferase of the mitochondrial outer membrane is important in the regulation of hepatic fatty acid oxidation; (b) to establish the mechanism by which the ki of carnitive palmitoyltransferase for malonyl-CoA is altered in various physiological and pathophysiological states; (c) to ascertain what mechanisms are involved in the control of carnitive palmitoyltransferase activity by insulin and thyroid hormone; (d) to determine whether additional hormonal control mechanisms exist for regulation hepatic fatty acid oxidation through changes in carnitive palmitoyltransferase or modification of other hormonal signals; (e) to isolate, purify, characterize, and produce antibodies to the inner carnitive palmitoyltransferase; and (g) to examine the effects of fasting, refeeding, insulin and thyroid hormone on the synthesis of carnitive palmitoyltransferase messenger RNA's These objectives will be achieved by conducting experiments in vivo and in vitro using normal rats, isolated rat hepatocytes, cultured hepatocytes, isolated rat liver mitochondria isolated mitochondrial outer membranes, and isolated, purified carnitive palmitoyltransferase. These studies, performed at organizational levels ranging from the intact animal level down to the molecular level, will contribute greatly to our understanding of the regulation of hepatic fatty acid oxidation and its integration into the control of hepatic lipid and lipoprotein metabolism.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL040929-02
Application #
3358308
Study Section
Metabolism Study Section (MET)
Project Start
1988-08-01
Project End
1993-07-31
Budget Start
1989-08-01
Budget End
1990-07-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Tennessee Health Science Center
Department
Type
Schools of Medicine
DUNS #
941884009
City
Memphis
State
TN
Country
United States
Zip Code
38163
Kashfi, Khosrow; Mynatt, Randall L; Park, Edwards A et al. (2011) Membrane microenvironment regulation of carnitine palmitoyltranferases I and II. Biochem Soc Trans 39:833-7
Kashfi, K; Cook, G A (1999) Topology of hepatic mitochondrial carnitine palmitoyltransferase I. Adv Exp Med Biol 466:27-42
Kashfi, K; Cook, G A (1995) Temperature effects on malonyl-CoA inhibition of carnitine palmitoyltransferase I. Biochim Biophys Acta 1257:133-9
Kashfi, K; Cagen, L; Cook, G A (1995) Diabetes and proteolysis: effects on carnitine palmitoyltransferase-I and malonyl-CoA binding. Lipids 30:383-8
Park, E A; Mynatt, R L; Cook, G A et al. (1995) Insulin regulates enzyme activity, malonyl-CoA sensitivity and mRNA abundance of hepatic carnitine palmitoyltransferase-I. Biochem J 310 ( Pt 3):853-8
Mynatt, R L; Greenhaw, J J; Cook, G A (1994) Cholate extracts of mitochondrial outer membranes increase inhibition by malonyl-CoA of carnitine palmitoyltransferase-I by a mechanism involving phospholipids. Biochem J 299 ( Pt 3):761-7
Kashfi, K; Mynatt, R L; Cook, G A (1994) Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation. Biochim Biophys Acta 1212:245-52
Mynatt, R L; Cook, G A (1994) Modulation of the malonyl-CoA sensitivity of hepatic carnitine palmitoyltransferase (CPT) by phospholipids. Biochem Soc Trans 22:113S
Mynatt, R L; Park, E A; Thorngate, F E et al. (1994) Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity. Biochem Biophys Res Commun 201:932-7
Cook, G A; Mynatt, R L; Kashfi, K (1994) Yonetani-Theorell analysis of hepatic carnitine palmitoyltransferase-I inhibition indicates two distinct inhibitory binding sites. J Biol Chem 269:8803-7

Showing the most recent 10 out of 21 publications